Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Andrea Fandella"'
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 86, Iss 3, Pp 202-204 (2014)
Purpose: The management of mildly elevated (4.0-10.0 ng/ml) prostate specific antigen (PSA) is uncertain. Immediate prostate biopsy, antibiotic treatment, or monitoring PSA level for 1-3 months is still in controversy. Materials and Methods: We retro
Externí odkaz:
https://doaj.org/article/2979131026d846febc5114cd7a2868a6
Autor:
Sebastiano Spatafora, Antonio Casarico, Andrea Fandella, Caterina Galetti, Rodolfo Hurle, Elisa Mazzini, Ciro Niro, Massimo Perachino, Roberto Sanseverino, Giovanni Luigi Pappagallo
Publikováno v:
Therapeutic Advances in Urology, Vol 4 (2012)
Background: The first Italian national guidelines were developed by the Italian Association of Urologists and published in 2007. Since then, a number of new drugs or classes of drugs have emerged for the treatment of lower urinary tract symptoms (LUT
Externí odkaz:
https://doaj.org/article/86d0fb2d768445dc95177c4a93f728e6
Autor:
Giulia Rainato, Aline S.C. Fabricio, Andrea Fandella, Vincenzo Scattoni, Matelda Zancan, Massimo Gion, Lucia Peloso, Ruggero Dittadi, M Barichello
Publikováno v:
The International Journal of Biological Markers. 31:317-323
Background Prostate-specific antigen (PSA) lacks specificity and sensitivity in discriminating prostate cancer (PCa) from benign prostatic hyperplasia (BPH) when the total PSA (tPSA) level is between 4 and 10 ng/mL. It remains to be investigated if a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39ce167ffa17053e6d8e759bff62c96
https://doi.org/10.5301/jbm.5000200
https://doi.org/10.5301/jbm.5000200
Autor:
Andrea Fandella, Pietro Pepe
Publikováno v:
Atlas of Ultrasonography in Urology, Andrology, and Nephrology ISBN: 9783319407807
PSA and/or rectal examination suspects remain the main indications for biopsy [1–4]. A prostate biopsy may be indicated for PSA values that exceed the thresholds of common use and almost always for values above 10 ng/ml; in this regard it is sugges
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a7a15ec0d81abc5f1d2d6be96e49de5
https://doi.org/10.1007/978-3-319-40782-1_26
https://doi.org/10.1007/978-3-319-40782-1_26
Autor:
Alessandro Bertaccini, Marco Giampaoli, Riccardo Cividini, Gian Luca Gattoni, Roberto Sanseverino, Tommaso Realfonso, Giorgio Napodano, Andrea Fandella, Elisa Guidoni, Raffaele Galasso, Carmine Cicalese, Vincenzo Scattoni, Angelo Armenio, Giario Conti, Matteo Corinti, Roberta Spasciani, Giovanni Liguori, Nikolitsa Lampropoulou, Giuseppe Martorana, PREZIOSO, DOMENICO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::a206946c3bd81c67459de773f9273048
http://hdl.handle.net/11588/517783
http://hdl.handle.net/11588/517783
Autor:
Elisa Mazzini, Massimo Perachino, Caterina Galetti, Andrea Fandella, Giovanni L. Pappagallo, Antonio Casarico, Roberto Sanseverino, Ciro Niro, Sebastiano Spatafora, Rodolfo Hurle
Publikováno v:
Therapeutic Advances in Urology, Vol 4 (2012)
Background: The first Italian national guidelines were developed by the Italian Association of Urologists and published in 2007. Since then, a number of new drugs or classes of drugs have emerged for the treatment of lower urinary tract symptoms (LUT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a51bac54570012f56e2e400399daac64
https://doaj.org/article/86d0fb2d768445dc95177c4a93f728e6
https://doaj.org/article/86d0fb2d768445dc95177c4a93f728e6
Autor:
Andrea Fandella
Publikováno v:
Urologia. 78(4)
Introduction Literature reports mortality and morbidity data from prostatic carcinoma which permit a better use of some routine diagnostic tools such as transrectal ultrasound-guided biopsy. The aim of this work is to quantify the overall cost of tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b1bea49cdea4712df0c31e69645d316
https://pubmed.ncbi.nlm.nih.gov/22139803
https://pubmed.ncbi.nlm.nih.gov/22139803
Publikováno v:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 83(2)
Population screening for prostatic carcinoma (CP) is a debated topic, and its real utility is still unknown. Nowadays only surveys on little groups or clinical randomized studies are recommended. In this study the male population of blood donors of o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eda732642c7b7597a2b3910c9774d8b6
https://pubmed.ncbi.nlm.nih.gov/21826878
https://pubmed.ncbi.nlm.nih.gov/21826878
Publikováno v:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 81(1)
The TNM classification should be a tool that allows the physician to make therapeutic decisions and gain even a prognostic scheme. Currently, the 2002 TNM classification for kidney cancer doesn't have these features. Really it doesn't make a distinct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::06cb80c3f67da2057c762fab3ee30f32
https://pubmed.ncbi.nlm.nih.gov/19499760
https://pubmed.ncbi.nlm.nih.gov/19499760
Publikováno v:
Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. 78(3)
Over the past ten years nephron sparing surgery for renal cancer has been compared to radical nephrectomy for what concern oncological results, even in elective situations but it is necessary to consider functional results (renal function) as well. C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::92101fdca5b5bb7f06fd75e30de0874b
https://pubmed.ncbi.nlm.nih.gov/17137028
https://pubmed.ncbi.nlm.nih.gov/17137028